Well Referenced

Tag: tadalafil

Comparison of the Clinical Efficacy of Daily Use of L-arginine, Tadalafil, and Combined L-arginine with Tadalafil in the Treatment of Elderly Patients with Erectile Dysfunction

This 2020 single-blind, placebo-controlled clinical trial assessed the efficacy of daily oral administration of L-arginine (5 g), tadalafil (5 mg), and their combination in 120 men aged ≥60 years with erectile dysfunction (ED). Participants were randomized into four groups (n=30 each) receiving L-arginine, tadalafil, combined therapy, or placebo for 6

Read More »
June 26, 2025 No Comments

Daily Oral l-Arginine Plus Tadalafil in Diabetic Patients with Erectile Dysfunction: A Double-Blinded, Randomized, Controlled Clinical Trial

This 2019 double-blind, randomized controlled trial evaluated the efficacy of daily oral l-arginine (2.5 g) combined with tadalafil (5 mg) in 108 diabetic men with mild to moderate erectile dysfunction (ED). Over an 8-week period, patients receiving the combination therapy exhibited significant improvements in International Index of Erectile Function-5 (IIEF-5)

Read More »
June 26, 2025 No Comments

Tadalafil once daily in men with erectile dysfunction: an integrated analysis of data obtained from 1913 patients from six randomized, double-blind, placebo-controlled, clinical studies

This integrated analysis evaluated the efficacy and safety of once-daily tadalafil at doses of 2.5 mg and 5 mg over 12 weeks in 1,913 men with erectile dysfunction (ED) across various subpopulations, including different ages, ethnicities, comorbidities, and ED characteristics. Both tadalafil doses significantly improved erectile function compared to placebo,

Read More »
June 26, 2025 No Comments

Treatment satisfaction of men and partners following switch from on-demand phosphodiesterase type 5 inhibitor therapy to tadalafil 5 mg once daily

This randomized controlled trial investigated the treatment satisfaction of men with erectile dysfunction (ED) and their partners after switching from on-demand phosphodiesterase type 5 (PDE5) inhibitors to a daily regimen of tadalafil 5 mg. The study included men aged 18 and older with a history of ED who had been

Read More »
June 26, 2025 No Comments